HealthcareServices

Global Leukocytosis Market Performance Report: Global Trends 2026–2030

February 26, 2026February 26, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the leukocytosis market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Leukocytosis Market between 2026 and 2030?

The leukocytosis market size has experienced robust expansion in recent years. It is projected to increase from $5.13 billion in 2025 to $5.41 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.4%. Historically, this growth has been fueled by the high prevalence of infectious diseases, the rising incidence of inflammatory disorders, an increasing number of leukemia cases, a dependence on conventional blood tests, and the expansion of hospital-based diagnostic services.

The leukocytosis market is projected to experience substantial expansion over the upcoming years. By 2030, this market is set to reach $6.63 billion, expanding at a compound annual growth rate (CAGR) of 5.2%. Factors contributing to this growth during the forecast period include progress in hematology diagnostics, a rise in the adoption of personalized treatment strategies, enhanced awareness regarding early disease identification, increased spending on healthcare, and the expansion of laboratory automation. Key trends anticipated during the forecast period encompass a greater uptake of sophisticated blood diagnostic methods, an intensified focus on treatments tailored to specific underlying diseases, an increase in the application of precision medicine within hematology, the proliferation of automated and high-throughput testing, and the broader integration of clinical decision support systems.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24278&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Leukocytosis Market?

The projected increase in the occurrence of blood-related diseases is anticipated to propel the leukocytosis market’s expansion moving forward. These medical conditions are characterized by their impact on various blood components, including red blood cells, white blood cells, platelets, or plasma. The prevalence of blood-related diseases is escalating, attributed to aging populations, as older individuals are more prone to conditions such as anemia, leukemia, and clotting disorders due to diminished immune function and accumulated health issues. Often, blood-related diseases lead to elevated white blood cell counts, which is a key indicator of leukocytosis, thereby emphasizing the necessity for improved early diagnosis, better monitoring tools, and more effective treatment options. For instance, in 2024, according to the American Cancer Society, a US-based cancer organization, 62,770 new cases of leukemia were reported, a notable increase from 59,610 cases in 2023. Thus, the escalating incidence of blood-related diseases is a key factor driving the growth of the leukocytosis market.

How Is The Leukocytosis Market Organized Into Various Segments?

The leukocytosis market covered in this report is segmented –

1) By Disease Type: Infection, Leukemia

2) By Diagnosis Type: Blood Tests, Bone Marrow Biopsy

3) By End User: Hospitals, Diagnostic Laboratories

Subsegments:

1) By Infection: Bacterial Infections, Viral Infections, Parasitic Infections, Fungal Infections

2) By Leukemia: Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia (ALL) with Hyperleukocytosis

Which Trends Are Influencing The Performance And Direction Of The Leukocytosis Market?

Key companies operating within the leukocytosis market are increasingly focusing on integrating artificial intelligence into diagnostic systems to enhance early detection, diagnostic accuracy, and personalized treatment planning. Artificial intelligence in diagnostic systems involves the utilization of artificial intelligence (AI) technologies such as machine learning, deep learning, and natural language processing to analyze medical data and either support or automate disease diagnosis. For instance, in December 2024, Koninklijke Philips NV, a Netherlands-based healthcare company, unveiled the CT 5300 system. This system incorporates proprietary artificial intelligence (AI) technologies to improve computed tomography (CT) imaging workflows. It features the computed tomography smart workflow, which includes artificial intelligence (AI)-driven tools like precise position, precise cardiac, and precise brain, designed to streamline scan preparation, boost diagnostic accuracy, and minimize radiation exposure.

Who Are The Core Companies Influencing Trends In The Leukocytosis Market?

Major companies operating in the leukocytosis market are Pfizer Inc., Johnson & Johnson, Siemens Healthineers AG, Roche Diagnostics AG, Bristol Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis International AG, Danaher Corporation, Merck KGaA, Becton Dickinson and Company (BD), Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics, Agilent Technologies Inc., Grifols SA, Hologic Inc., Illumina Inc., PerkinElmer Inc., Sysmex Corporation, Beckman Coulter Diagnostics Inc., Bio-Rad Laboratories, Bio-Techne Corporation, NeoGenomics Laboratories Inc., DiaSorin S.p.A.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/leukocytosis-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Leukocytosis Market?

North America was the largest region in the leukocytosis market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the leukocytosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Leukocytosis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24278&type=smp

Browse Through More Reports Similar to the Global Leukocytosis Market 2026, By The Business Research Company

Leukotriene Modifiers Market Report 2026

https://www.thebusinessresearchcompany.com/report/leukotriene-modifiers-global-market-report

Progressive Multifocal Leukoencephalopathy Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/progressive-multifocal-leukoencephalopathy-treatment-global-market-report

Pheochromocytoma Market Report 2026

https://www.thebusinessresearchcompany.com/report/pheochromocytoma-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795